Evaluating vaccines and chasing down 'breakthrough infection

Evaluating vaccines and chasing down 'breakthrough infections' are key to success


Evaluating vaccines and chasing down ‘breakthrough infections’ are key to success
Data generated from Sisonke study will prove to be invaluable to understanding of vaccines and their effectiveness
23 May 2021 - 17:47
The vaccination of health workers through the Sisonke study is done but the work is not, and chasing down “breakthrough infections” — when people get Covid after vaccination — is a priority, said the scientists in charge, profs Glenda Gray and Linda-Gail Bekker.
“Sisonke’s main cause was to prevent healthcare workers from getting very sick or dying. It was never about preventing infections. That is a bonus. There is no 100% prophylactic vaccine today,” said Bekker...

Related Keywords

Linda Gail Bekker , Glenda Gray , , Keeton Senior , Sisonke , Nomathemba Mokgethi , Health Workers , Sa Health Products Regulatory Authority , Institute Of Infectious Disease And Molecular Medicine , B 1 351 Variant , க்லெஂட சாம்பல் , கீடந் மூத்தவர் , ஆரோக்கியம் தொழிலாளர்கள் , ச ஆரோக்கியம் ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம் ,

© 2025 Vimarsana